Construction of Recombinant Mycobacterium smegmatis Expressing the Pro-Apoptotic Protein BIK and Its Impact on Macrophage Apoptosis
Pathogens · 17.08.2026 · 15 (8) · 857
DOI: 10.3390/pathogens15080857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 17.08.2026. Verfasst von Yaning Pang und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Ho…. Hauptthemen laut MEDLINE: Mycobacterium smegmatis, Apoptosis, Macrophages, Apoptosis Regulatory Proteins. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major global health threat. A key virulence mechanism involves the pathogen’s ability to inhibit apoptosis in infected macrophages, thereby facilitating immune evasion and persistent infection. The pro-apoptotic protein Bcl-2-interacting killer (BIK) represents a critical mediator of macrophage apoptosis. In this study, we engineered a recombinant Mycobacterium smegmatis strain (rMs-BIK) designed to secrete BIK via fusion with the Ag85B signal peptide (ASP). Secretion and expression of the BIK protein were confirmed by Western blotting. Quantitative flow cytometric analysis revealed that rMs-BIK induced significant apoptosis in RAW264.7 macrophages, with rates of 14.49%, 14.22%, and 22.24% at 12, 24, and 48 h post-infection, respectively. These values were markedly higher than those observed in cells infected with the wild-type strain (7.68%, 9.24%, and 10.90%) or the empty vector control (8.80%, 11.19%, and 14.43%). Our findings demonstrate the feasibility of functional pro-apoptotic protein delivery using a mycobacterial vector, providing a robust foundation for the future development of recombinant BCG-based vaccine candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen 518114…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pang, Y., & Bi, J. (2026). Construction of Recombinant Mycobacterium smegmatis Expressing the Pro-Apoptotic Protein BIK and Its Impact on Macrophage Apoptosis. Pathogens, 15(8), 857. https://doi.org/10.3390/pathogens15080857
Vancouver
Pang Y, Bi J. Construction of Recombinant Mycobacterium smegmatis Expressing the Pro-Apoptotic Protein BIK and Its Impact on Macrophage Apoptosis. Pathogens. 2026;15(8):857. doi:10.3390/pathogens15080857
BibTeX
@article{Pang2026,
author = {Pang, Yaning and Bi, Jing},
title = {Construction of Recombinant Mycobacterium smegmatis Expressing the Pro-Apoptotic Protein BIK and Its Impact on Macrophage Apoptosis},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {8},
pages = {857},
doi = {10.3390/pathogens15080857}
}
EUVIMED